×
About 669 results

ALLMedicine™ Meningococcal Meningitis Center

Research & Reviews  327 results

Meningococcal vaccines in China.
https://doi.org/10.1080/21645515.2020.1857201
Human Vaccines & Immunotherapeutics; Xu Y, Li Y et. al.

Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...

Meningococcal vaccines and protein-energy undernutrition in children in the African men...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751252
Vaccine Sundaram ME, Wolfson J et. al.

Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...

Herpes simplex virus type 2 myelitis mimicking ICU-acquired weakness as a complication ...
https://doi.org/10.1016/j.ijid.2020.11.134
International Journal of Infectious Diseases : IJID : Off... Tsutsumi K, Saito H et. al.

Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...

Structure of a protective epitope reveals the importance of acetylation of Neisseria me...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703565
Proceedings of the National Academy of Sciences of the Un... Henriques P, Dello Iacono L et. al.

Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...

4CMenB vaccine induces elite cross-protective human antibodies that compete with human ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556464
PLoS Pathogens; Veggi D, Bianchi F et. al.

Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...

see more →

Guidelines  3 results

Protecting the world against meningitis: new recommendations from the CDC's advisory co...
https://www.ncbi.nlm.nih.gov/pubmed/22086889
The Journal of the American Osteopathic Association; Cyrus SS,

Dec 6th, 2011 - Meningococcal meningitis is a rare but often fatal disease. Throughout adolescence, the incidence of meningococcal meningitis increases, reaching a peak among individuals between the ages of 16 and 21 years. Vaccines are available to combat this d...

Differential Diagnosis of Meningococcal Meningitis Based on Common Clinical and Laboratory Findings: Are There Criterion Standards?
https://journals.lww.com/infectdis/Abstract/2010/07000/Differential_Diagnosis_of_Meningococcal_Meningitis.9.aspx
Infectious Diseases in Clinical Practice; Fretzayas,A.,et al

Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...

Now Approved | MenQuadfi (Meningococcal [Groups A, C, Y, W and Y)
https://www.menquadfi.com/

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  333 results

Meningococcal vaccines in China.
https://doi.org/10.1080/21645515.2020.1857201
Human Vaccines & Immunotherapeutics; Xu Y, Li Y et. al.

Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...

Meningococcal vaccines and protein-energy undernutrition in children in the African men...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751252
Vaccine Sundaram ME, Wolfson J et. al.

Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...

Herpes simplex virus type 2 myelitis mimicking ICU-acquired weakness as a complication ...
https://doi.org/10.1016/j.ijid.2020.11.134
International Journal of Infectious Diseases : IJID : Off... Tsutsumi K, Saito H et. al.

Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...

Structure of a protective epitope reveals the importance of acetylation of Neisseria me...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703565
Proceedings of the National Academy of Sciences of the Un... Henriques P, Dello Iacono L et. al.

Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...

4CMenB vaccine induces elite cross-protective human antibodies that compete with human ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556464
PLoS Pathogens; Veggi D, Bianchi F et. al.

Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...

see more →

News  3 results

Teens Without Vaccines
https://www.medscape.com/viewarticle/807225

Jul 7th, 2013 - Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010 Darden PM, Thompson DM, Roberts JR, et al Pediatrics. 2013;131:645-651 Vaccinating Teens Healthy People 2020 goals for adolescent immunization rates are 90% ...

Differential Diagnosis of Meningococcal Meningitis Based on Common Clinical and Laboratory Findings: Are There Criterion Standards?
https://journals.lww.com/infectdis/Abstract/2010/07000/Differential_Diagnosis_of_Meningococcal_Meningitis.9.aspx
Infectious Diseases in Clinical Practice; Fretzayas,A.,et al

Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...

Now Approved | MenQuadfi (Meningococcal [Groups A, C, Y, W and Y)
https://www.menquadfi.com/

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...

see more →